Akorn Wants Derivative Suit Related To Failed Merger Axed
Akorn Inc. told an Illinois federal judge on Monday that a shareholder's consolidated derivative suit claiming the pharmaceutical company's falsified regulatory submissions sunk a multibillion-dollar merger and tanked Akorn's share price...To view the full article, register now.
Already a subscriber? Click here to view full article